The Burden of respiratory syncytial virus infection in young children

New England Journal of Medicine

Volumn 360, Issue 6, 2009, Pages 588-598

  Hall, Caroline Breese ^a,b,c   Weinberg, Geoffrey A ^a   Iwane, Marika K ^d   Blumkin, Aaron K ^a   Edwards, Kathryn M ^e   Staat, Mary A ^g,h   Auinger, Peggy ^a   Griffin, Marie R ^f   Poehling, Katherine A ^e   Erdman, Dean ^d   Grijalva, Carlos G ^f   Zhu, Yuwei ^b   Szilagyi, Peter ^a  

^a Departments of Pediatrics   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^e Departments of Medicine and Pediatrics   (United States)

^f Preventive Medicine   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

AMBULATORY CARE; ARTICLE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEALTH SURVEY; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MORBIDITY; OUTPATIENT; PARENT; PREMATURITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; UNITED STATES; VIRAL RESPIRATORY TRACT INFECTION; VIRUS CULTURE; VIRUS DETECTION; CHI SQUARE DISTRIBUTION; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; ISOLATION AND PURIFICATION; NEWBORN; RESPIRATORY TRACT INFECTION; STATISTICAL MODEL; STATISTICS; UTILIZATION REVIEW; VIROLOGY; VIRUS INFECTION;

AMBULATORY CARE; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; UNITED STATES;

EID: 59749095702     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0804877     Document Type: Article

References (37)

1. The Jordan Report: accelerated development of vaccines 2002. Bethesda, MD: National Institute of Allergy and Infectious Diseases, 2002. (Accessed January 12, 2009, at http://www3.niaid.nih.gov/topics/Malaria/PDF/jordan20-2002. pdf.)
2. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-28.
3. Boyce TG, Mellen BG, Mitchel EF Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865-70.
4. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
5. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143:Suppl:S127-S132.
6. Holberg CJ, Wright AL, Martinez FD, Ray CG, Taussig LM, Lebowitz MD. Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. Am J Epidemiol 1991;133:1135-51.
7. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
8. Peck AJ, Holman RC, Curns AT, et al. Lower respiratory tract infections among American Indian and Alaska Native children and the general population of U.S. children. Pediatr Infect Dis J 2005;24:342-51.
9. Weinberg GA, Erdman DD, Edwards KM, et al. Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis 2004;189:706-10.
10. Erdman DD, Weinberg AG, Edwards KM, et al. GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol 2003;41:4298-303.
11. Mullins JA, Erdman DD, Weinberg GA, et al. Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis 2004;10:700-5.
12. Iwane MK, Edwards KM, Szilagyi PG, et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics 2004;113:1758-64.
13. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40.
14. Miller EK, Griffin MR, Edwards KM, et al. Influenza burden for children with asthma. Pediatrics 2008;121:1-8.
15. Miller EK, Lu X, Erdman DD, et al. Rhinovirus-associated hospitalizations in young children. J Infect Dis 2007;195:773-81.
16. Griffin MR, Walker FJ, Iwane MK, Weinberg GA, Staat MA, Erdman DD. Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J 2004;23:Suppl:S188-S192.
17. Weinberg GA, Hall CB, Iwane MK, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr (in press).
18. Properties of a random sample. In: Casella G, Berger RL, eds. Statistical inference. 2nd ed. Pacific Grove, CA.: Duxbury/Thomson Learning, 2002:240-5.
19. StataCorp. Stata statistical software: release 10. College Station, TX: StataCorp, 2007.
20. Schanzer DL, Langley JM, Tam TW. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr Infect Dis J 2006;25:795-800.
21. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342:232-9.
22. Nicholson KG, McNally T, Silverman M, Simons P, Stockton JD, Zambon MC. Rates of hospitalisation for influenza, respiratory syncytial virus and human meta-pneumovirus among infants and young children. Vaccine 2006;24:102-8.
23. Nokes DJ, Okiro EA, Ngama M, et al. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya. Clin Infect Dis 2008;46:50-7.
24. Collins PL, Murphy BR. New generation live vaccines against human respiratory syncytial virus designed by reverse genetics. Proc Am Thorac Soc 2005;2:166-73.
25. Englund J. In search of a vaccine for respiratory syncytial virus: the saga continues. J Infect Dis 2005;191:1036-9.
26. van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J. Immunopathology of RSV infection: prospects for developing vaccines without this complication. Rev Med Virol 2007;17:5-34.
27. Welliver RC. Respiratory syncytial virus infection: therapy and prevention. Paediatr Respir Rev 2004;Suppl:S127-S133.
28. Meissner HC, Rennels MB, Pickering LK, Hall CB. Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab. Pediatr Infect Dis J 2004;23:284-5.
29. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 2003;143:Suppl:S118- S126.
30. Nielsen HE, Siersma V, Andersen S, et al. Respiratory syncytial virus infection - risk factors for hospital admission: a case-control study. Acta Paediatr 2003;92:1314-21.
31. Reeve CA, Whitehall JS, Buettner PG, Norton R, Reeve DM, Francis F. Predicting respiratory syncytial virus hospitalisation in Australian children. J Paediatr Child Health 2006;42:248-52.
32. Bradley JP, Bacharier LB, Bonfiglio J, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics 2005;115(1):e7-e14.
33. von Linstow ML, Høgh M, Nordbø SA, Eugen-Olsen J, Koch A, Høgh B. A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr 2008;167:1125-33.
34. Carbonell-Estrany X, Figueras-Aloy J, Law BJ. Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings. Pediatr Infect Dis J 2004;23:Suppl:S193-S201.
35. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J 2004;23:806-14.
36. Rossi GA, Medici MC, Arcangeletti MC, et al. Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur J Pediatr 2007;166:1267-72.
37. Romero JR. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J 2003;22:Suppl:S46-S54.